Showing results (21-30 of 99) with videos related to
Sort By:
Pageof 10
Immuno-Oncology Technology|August 20, 2026
Management of systemic lupus erythematosus and antiphospholipid syndrome during CAR-T therapy: insights from two clinical casesC Normand, S Almaz, R Stadelmann, et al.Immuno-Oncology Technology|August 14, 2026
Germline BRCA1 pathogenic variants and T cell dysfunctionJ Kay, M A Harris, L E Lara Gonzalez, et al.Immuno-Oncology Technology|January 13, 2025
Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanomaT J Monberg, T Kudling, B Albieri, et al.Immuno-Oncology Technology|September 18, 2024
A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer modelsI Tsimafeyeu, P Makhov, D Ovcharenko, et al.Immuno-Oncology Technology|February 6, 2025
Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancersJ Palomero, V Galvao, I Creus, et al.Immuno-Oncology Technology|June 27, 2022
Nanobodies as non-invasive imaging toolsM Rashidian, H PloeghImmuno-Oncology Technology|June 27, 2022
Quantitative RNA assessment and long-term stability in the FFPE tumor samples using Digital Spatial ProfilerS Gupta, T Chen, B DestenavesImmuno-Oncology Technology|June 27, 2022
Gene editing: Towards the third generation of adoptive T-cell transfer therapiesCristina Puig-Saus, Antoni RibasImmuno-Oncology Technology|June 27, 2022
A user's perspective on GeoMxTM digital spatial profilingTrieu My Van, Christian U BlankImmuno-Oncology Technology|June 27, 2022
Clinical landscape of LAG-3-targeted therapyL Chocarro, E Blanco, H Arasanz, et al.Pageof 10